Mr. David Raffa reports

T-BIRD PHARMA INC. APPOINTS SANDY PRATT AS CHIEF FINANCIAL OFFICER

T-Bird Pharma Inc. has appointed Sandra (Sandy) Pratt as chief financial officer, replacing Chris Taylor, who has stepped down to return to his private practice. Mr. Taylor will remain involved with the company at the board level by continuing on as corporate secretary and operationally as an RPIC and consultant. "Chris's background in our history and operations is valuable so we are very pleased to see that he has agreed to remain involved with the company at the board level," noted David Raffa, chairman of the board. Added Mr. Raffa: "The addition of Sandy to our team represents another step in increasing the operational experience within our company as we commercialize our operation. We are very pleased she has agreed to join our team."

Ms. Pratt is a CPA/CA who began her career in public practice with Deloitte, where she had a large number of public and private company clients. Ms. Pratt left private practice to join Angiotech in its early stages and experienced the challenges and excitement of being a core member of a high-growth pharma company. During her tenure with Angiotech, first as controller and then as director of finance, the company grew from an organization of two to 45 companies, and from prerevenue to over $300-million in revenues. Ms. Pratt was a key part of the finance and mergers and acquisitions teams.

More recently, Ms. Pratt served as vice-president of finance at the Oak Bay Marine Group where her duties covered all aspects of financial operations. In addition to her finance role, she also led sales and marketing and was co-responsible for all aspects of the conglomerate's operations together with one other senior officer. "It is Sandy's broad operational experience that attracted us to her," noted Dr. Bin Huang, chief executive officer of the company. "Sandy's skill set goes beyond that of a typical CFO having been involved at various points in her career with operations, business development, sales and marketing and human resources."

Ms. Pratt has been granted an option to acquire up to 350,000 common shares vesting over three years.

We seek Safe Harbor.